This content is restricted to site members. If you are an existing user, please log in. New users may register below.
Soliton to Initiate POC Clinical Trials to Treat Fibrotic Scars Using Acoustic Shockwaves
Soliton, Inc., a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), announced that it